RICHARD J. MEELIA

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

HAEMONETICS CORP

Filing Date Source Excerpt
2013-06-17 This past year, leadership was provided by the Chairman of the Board, Richard J. Meelia, an independent Director.
2014-06-13 Mr. Meelia, 65, joined the Board of Directors and assumed the role of Chairman in 2011.
2015-06-11 Mr. Meelia, 66, joined the Board of Directors and assumed the role of Chairman in 2011.
2016-06-10 Mr. Meelia, 67, joined the Board of Directors and assumed the role of Chairman in 2011. He is a member of the Audit Committee and Governance and Compliance Committee.
2017-06-12 Mr. Meelia, 68, joined the Board of Directors and assumed the role of Chairman in 2011. Compensation for the Board of Directors in fiscal 2017 was $238,477 for Mr. Meelia.
2018-06-12 Richard J. Meelia (Chairman) Principal, Meelia Ventures, Inc.; Retired Chairman, President and CEO, Covidien plc Age: 69 Mr. Meelia joined our Board and assumed the role of Chairman in 2011. DIRECTOR COMPENSATION TABLE FOR FISCAL YEAR ENDED MARCH 31, 2018 Richard J. Meelia Fees Earned or Paid in Cash ($): 250,000 Stock Awards ($): 170,000 Total ($): 420,000
2019-06-12 Richard J. Meelia Principal, Meelia Ventures, LLC; Retired Chairman, President and CEO, Covidien plc. Age: 70. Mr. Meelia joined our Board and assumed the role of Chairman in 2011. Director Compensation Table for Fiscal Year Ended March 30, 2019 shows total compensation of $419,939.
2020-06-08 Richard J. Meelia Principal, Meelia Ventures, LLC; Retired Chairman, President and Chief Executive Officer, Covidien plc Age: 71 Mr. Meelia joined our Board and assumed the role of Chairman in 2011. Mr. Meelia is currently a principal of Meelia Ventures, LLC, a private equity firm focused on early stage healthcare companies. From July 2007 until his retirement in July 2011, Mr. Meelia served as Chairman, President, and Chief Executive Officer of Covidien plc, a global healthcare company, following its separation from Tyco International in June 2007. Prior to that separation, Mr. Meelia served in a variety of senior leadership roles, including Chief Executive Officer and President of Tyco Healthcare. Mr. Meelia joined Kendall Healthcare Products Company, the foundation of both the Tyco Healthcare Business and Covidien, as Group President in 1991. Mr. Meelia previously served on the Board of Apollo Endosurgery, Inc. and served on the Company’s Board from 2005 to 2009. In addition to his public company board service, Mr. Meelia is a member of the Board of Trustees of St. Anselm College and Elms College and serves on the Board of two non-profit charities, Por Christo and St. Francis House.

Data sourced from SEC filings. Last updated: 2025-08-30